𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Caffeine for treatment of Parkinson disease: A randomized controlled trial

✍ Scribed by Postuma, R. B.; Lang, A. E.; Munhoz, R. P.; Charland, K.; Pelletier, A.; Moscovich, M.; Filla, L.; Zanatta, D.; Rios Romenets, S.; Altman, R.; Chuang, R.; Shah, B.

Book ID
115466262
Publisher
Lippincott Williams and Wilkins
Year
2012
Tongue
English
Weight
495 KB
Volume
79
Category
Article
ISSN
0028-3878

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylphenidate improves fatigue scores
Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial
✍ Dan A. Mendonça; Krishe Menezes; Mandar S. Jog 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Fatigue is a common nonmotor symptom in idiopathic Parkinson disease (IPD) that can prominently affect everyday function. This study was a randomized, double‐blind, placebo‐controlled trial evaluating methylphenidate for the treatment of fatigue in patients with IPD maintained on their

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s